Skip to main content

How E-Pharmacy is changing the game?

Well right now mostly 60% people in India are buying medicines online and this number is increasing.

The current mentality of people is parted in two ways:- First comes the one who want to buy medicines online and second who don't.

There are major players in the industry who had already captured market share and are keen on expanding more.

Some famous players in the E-Pharma race includes:-

1:- PharmEasy

PharmEasy was started in 2015 with the aim of delivering medicines online. The startup was pivoted as well frequently.

They are now heading for an IPO at a valuation of $9 Billion.

Recently they acquired MEDLIFE and  Thyrocare.

2:- 1mg

1mg was started in 2015.

3:- Netmeds

It was started in 2015.

Also known as "India ki Pharmacy".

4:- MedPlus

It was started in 2006.

Recently, Apollo Hospitals also entered in this segment and are spending heavily on advertising.

Medkart Pharmacy too delivers online medicine.


E-Pharmacy is all set to disrupt this industry in India as well as many foreign countries.

In Canada, a startup called Pocket Pills is capturing the market share of e-pharmacy.

In the long run, these companies will spend heavily on advertising and gathering customers.

Also some big businessmen including Ratan Tata, Mukesh Ambani are entering into the segment with the acquisition of already existing players.

This E-Pharma race is just getting started and blogs on this topic will be more detailed in the near future.

Stay tuned!!




Comments

Popular posts from this blog

Top Pharmacy Franchises in India

If you atleast know something about medicines and pharma franchises, this blog is all about that.   For pharmacists and pharmacy students, it's super easy because they have their own drug licenses. If you are a pharmacist then don't wait for a 9 to 5 job. Start your own. So there are some top Pharmacy Franchises in India which you must know. 1:- Apollo Pharmacy Apollo pharmacy is one of the well-known retail pharmacy chains in India. They made 1,150 cores turnover in the last financial year. They have more than 5000 products. Different types of medicines, vitamins, and supplements, baby care, personal care, health foods, oral care, skincare, and over-the-counter (OTC) products. Apollo pharmacy franchise cost: The cost of investment is Rs 5 to 10 lakh rupees and commercial retail space to open the pharmacy store. For open apollo pharmacy contact here: Contact Number: (044) 28245800 | Customer Care Toll-Free No: 1860 500 0101 2:- Medplus Medplus is another big company in the phar...

What is RCPA in Pharma?

  RCPA stands for  Retail Chemist Prescription Audit.  It’s a sales survey tool which is used to gather the c ompetitor Knowledge.   Retail chemist Prescription Audit is the important concept in pharmaceutical product management and sales management. Pharma distribution network starts from stockist appointed by company.  Stocks then distributed to retail chemists.  When doctor prescribes the product to patient, patients buys at retail chemist.  This way the sales are done.   Here you will find actual consumer is patient and indirect consumer is doctor because he prescribes the product.  You never come in direct contact with consumer. That is why pharma selling is different from other selling.  Here  retailer will stock products of various companies and has got significant role to influence your selling . 

OTC Medicines

  Over-the-counter medicine is also known as OTC or nonprescription medicine. All these terms refer to medicine that you can buy without a prescription. They are safe and effective when you follow the directions on the label and as directed by your health care professional. In November 2016, India's Drug Consultative Committee announced it was embarking on establishing a definition of drugs which could be dispensed without a prescription.  Prior to this, the general assumption was that any drug which did not fall into a prescription schedule could be purchased without a prescription.  However, the needed definition had not been enacted by early 2018. The lack of a legal definition for OTC drugs has led to this  US$4 billion  market segment being effectively unregulated.